Flex Pharma (FLKS) Tops Q3 EPS by 7c

Flex Pharma (NASDAQ: FLKS) reported Q3 EPS of ($0.65), $0.07 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $586 thousand versus the consensus estimate of $110 thousand.

For earnings history and earnings-related data on Flex Pharma (FLKS) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Advance Auto Parts falls on revenue miss, weak guidance
• China semiconductor equipment imports grow 9% in July, Barclays comments